Matrix Pharmaceutical (MATX) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Matrix Pharmaceutical (MATX)

MATX 132.00

+0.7%

Jan 9 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Steve Powers who wrote ()	10/6/1999 12:34:00 PM
From: george	Read Replies (2) of 240

MATX: Products, Cash, News, Attractive Valuation Driving toward pivotal data, NDA filing IntraDose activity and safety profile demonstrated in hundreds of patients IntraDose has multiple potential indications Pipeline also includes FMdC for systemic chemotherapy MPI 5020 for use with radiotherapy 2+ years of cash ($2.50 per share) on hand i like it!!!!!!!!!!!!!!!!!!george

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next